Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study will compare the efficacy and safety of once daily treatment of LEO 19123 cream
versus Dovonex® cream (applied twice daily) and versus LEO 19123 cream vehicle alone (applied
twice daily) in subjects with psoriasis vulgaris. Subject will be treated for 4 weeks. All
subjects will apply LEO 19123 cream to psoriasis lesions on the left or right side of the
body and either Dovonex® cream or cream vehicle to lesions on the other side.